BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES

Core Insights - Bio-Techne Corporation will present at multiple investor conferences in November 2024, including the UBS Global Healthcare Conference, Stifel 2024 Healthcare Conference, and Stephens NASH 2024 Conference [1] Company Overview - Bio-Techne Corporation is a global life sciences company that provides innovative tools and bioactive reagents for research and clinical diagnostics [2] - The company generated approximately $1.2 billion in net sales in fiscal 2024 and employs around 3,100 people worldwide [2]